Compare PGEN & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | REAL |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2013 | 2019 |
| Metric | PGEN | REAL |
|---|---|---|
| Price | $3.58 | $8.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $8.33 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 4.2M | 3.8M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.55 |
| EPS | ★ N/A | N/A |
| Revenue | $230,981,000.00 | ★ $692,845,000.00 |
| Revenue This Year | $1,115.92 | $14.30 |
| Revenue Next Year | $81.04 | $10.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.38 |
| 52 Week Low | $1.38 | $4.71 |
| 52 Week High | $5.47 | $17.39 |
| Indicator | PGEN | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 36.15 | 36.42 |
| Support Level | $3.49 | $8.69 |
| Resistance Level | $3.64 | $12.87 |
| Average True Range (ATR) | 0.27 | 0.52 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 7.39 | 4.40 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.